Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Pharmaxis Ltd ( (AU:SNT) ) has issued an update.
Pharmaxis Ltd presented interim results at the 66th American Society of Hematology annual meeting, with further data expected in 2025. These results, while preliminary, are part of the company’s ongoing efforts to develop and commercialize its product pipeline, which may influence its strategic direction and stakeholder interest.
More about Pharmaxis Ltd
YTD Price Performance: -12.50%
Average Trading Volume: 4,896,654
Technical Sentiment Consensus Rating: Hold
Current Market Cap: A$110.6M
Learn more about SNT stock on TipRanks’ Stock Analysis page.